# VITROS Immunodiagnostic Products NT-proBNP II

> **NCT03548909** · — · COMPLETED · sponsor: **Ortho-Clinical Diagnostics, Inc.** · enrollment: 3246 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DIAGNOSTIC_TEST:** VITROS Immunodiagnostic Products

## Key facts

- **NCT ID:** NCT03548909
- **Lead sponsor:** Ortho-Clinical Diagnostics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-06
- **Primary completion:** 2019-10-17
- **Final completion:** 2019-10-17
- **Target enrollment:** 3246 (ACTUAL)
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03548909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03548909, "VITROS Immunodiagnostic Products NT-proBNP II". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03548909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*